HBV humanized antibodies (Aprogen)

N/A

Report date: 2023/02/04 20:21:28

Base Information

Drug NameHBV humanized antibodies (Aprogen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAprogen

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAprogen

Active IndicationsN/A

Inactive IndicationsHepatitis B

ATC CodeN/A